Short communication · 2018
EditorialPublished 28 Feb 2025
Overcoming ?-Cell Dysfunction in Type 2 Diabetes Mellitus
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction. While insulin resistance often initiates the disease, it is the failure of β-cells to compensate that drives hyperglycemia and disease progression. Preserving or restoring β-cell function is thus a critical goal in T2DM management. This review outlines the underlying mechanisms of β-cell dysfunction, including glucotoxicity, lipotoxicity, oxidative stress, and inflammation. It also explores current and emerging strategies to overcome β-cell failure, such as lifestyle interventions, pharmacological agents, incretin-based therapies, islet regeneration, and novel cellular approaches. Targeting β-cell dysfunction offers the potential to halt or even reverse T2DM, paving the way for personalized and durable therapeutic strategies.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2 Apr 2021
Barriers to Patient Engagement in Managing Type 2 Diabetes Mellitus and How to Overcome It?
Review article · 15 Nov 2021
Type 2 diabetes mellitus and thyroid dysfunction: an intertwined duo
Conference abstract · 5 Feb 2020
Prevalence of erectile dysfunction among Egyptian male patients with type 2 diabetes mellitus
Research article · 25 Sep 2019
Delayed Visual Evoked Response is Linked to Vascular Endothelial Growth Factor and Autonomic Dysfunction in Type 2 Diabetes Mellitus
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Community diabetes prevention: Effective, global impact
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Rajesh Kumar”
